Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Clinical pharmacokinetics of bupropion: a review.

Lai AA, Schroeder DH.

J Clin Psychiatry. 1983 May;44(5 Pt 2):82-4. Review.

PMID:
6406470
2.

Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects.

Findlay JW, Van Wyck Fleet J, Smith PG, Butz RF, Hinton ML, Blum MR, Schroeder DH.

Eur J Clin Pharmacol. 1981;21(2):127-35.

PMID:
6804243
3.

Metabolism and kinetics of bupropion.

Schroeder DH.

J Clin Psychiatry. 1983 May;44(5 Pt 2):79-81.

PMID:
6406469
4.

The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses.

Posner J, Bye A, Dean K, Peck AW, Whiteman PD.

Eur J Clin Pharmacol. 1985;29(1):97-103.

PMID:
3932079
5.

Radioimmunoassay and pharmacokinetic profile of bupropion in the dog.

Butz RF, Schroeder DH, Welch RM, Mehta NB, Phillips AP, Findlay JW.

J Pharmacol Exp Ther. 1981 Jun;217(3):602-10.

PMID:
6785419
6.

Review of bupropion.

Bryant SG, Guernsey BG, Ingrim NB.

Clin Pharm. 1983 Nov-Dec;2(6):525-37. Review.

PMID:
6140095
7.

The effect of H2-antagonists on the absorption of bupropion in rats.

al-Khamis KI, Kaka JS, Tanira MO.

Res Commun Chem Pathol Pharmacol. 1988 Feb;59(2):279-82.

PMID:
2895943
8.

Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose.

Laizure SC, DeVane CL, Stewart JT, Dommisse CS, Lai AA.

Clin Pharmacol Ther. 1985 Nov;38(5):586-9.

PMID:
3931955
9.

Phenytoin-bupropion interaction: effect on plasma phenytoin concentration in the rat.

Tekle A, al-Khamis KI.

J Pharm Pharmacol. 1990 Nov;42(11):799-801.

PMID:
1982306
10.

Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.

Huupponen R, Karhuvaara S, Anttila M, Vuorilehto L, Scheinin H.

Clin Pharmacol Ther. 1995 Nov;58(5):506-11.

PMID:
7586944
11.

Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease.

DeVane CL, Laizure SC, Stewart JT, Kolts BE, Ryerson EG, Miller RL, Lai AA.

J Clin Psychopharmacol. 1990 Oct;10(5):328-32.

PMID:
2124217
12.

Effect of hepatic and renal dysfunction on disposition of bupropion in rats.

Kaka JS, Al-Khamis KI, Tanira MO.

Eur J Drug Metab Pharmacokinet. 1988 Jul-Sep;13(3):149-53.

PMID:
3149241
13.

Pharmacokinetics and absolute bioavailability of diltiazem in humans.

Ochs HR, Knüchel M.

Klin Wochenschr. 1984 Apr 2;62(7):303-6.

PMID:
6727272
14.

Absorption and excretion of a new antidepressive (SQ 10,996) in humans.

Vukovich RA, Dreyfuss J, Schreiber EC, Neiss ES.

Int J Clin Pharmacol Biopharm. 1976 Apr;13(3):182-6.

PMID:
950260
15.

Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.

Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.

Arzneimittelforschung. 1993 Oct;43(10):1084-94.

PMID:
8267675
16.

Pharmacokinetics of 14C-delmopinol in the healthy male volunteer.

Eriksson B, Ottersgård Brorsson AK, Hallström G, Sjödin T, Gunnarsson PO.

Xenobiotica. 1998 Nov;28(11):1075-81.

PMID:
9879639
17.

Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses.

Ferron GM, Rochdi M, Jusko WJ, Scherrmann JM.

J Clin Pharmacol. 1996 Oct;36(10):874-83.

PMID:
8930773
18.

Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.

Meyer MC, Straughn AB, Lo MW, Schary WL, Whitney CC.

J Clin Psychiatry. 1984 Sep;45(9 Pt 2):15-9.

PMID:
6469932
19.

Pharmacokinetics of toloxatone in man following intravenous and oral administrations.

Benedetti MS, Rovei V, Dencker SJ, Nagy A, Johansson R.

Arzneimittelforschung. 1982;32(3):276-80.

PMID:
7200786
20.

Bupropion hydrochloride.

Dufresne RL, Weber SS, Becker RE.

Drug Intell Clin Pharm. 1984 Dec;18(12):957-64. Review.

PMID:
6439541

Supplemental Content

Support Center